Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients.
Fumagalli C, Betella I, Rappa A, di Giminiani M, Gaiano M, De Vitis LA, Zambetti B, Vacirca D, Multinu F, Venetis K, Colombo N, Barberis M, Guerini Rocco E. Fumagalli C, et al. Among authors: betella i. Cancers (Basel). 2022 Mar 23;14(7):1638. doi: 10.3390/cancers14071638. Cancers (Basel). 2022. PMID: 35406410 Free PMC article.
Microsatellite instability evaluation: which test to use for endometrial cancer?
Rafaniello-Raviele P, Betella I, Rappa A, Vacirca D, Tolva G, Guerrieri-Gonzaga A, Bertario L, Barberis M, Bonanni B, Marabelli M. Rafaniello-Raviele P, et al. Among authors: betella i. J Clin Pathol. 2023 Jan;76(1):29-33. doi: 10.1136/jclinpath-2021-207723. Epub 2021 Jul 26. J Clin Pathol. 2023. PMID: 34312297
A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer.
Betella I, Fumagalli C, Rafaniello Raviele P, Schivardi G, De Vitis LA, Achilarre MT, Aloisi A, Garbi A, Maruccio M, Zanagnolo V, Aletti G, Guerini-Rocco E, Mariani A, Maggioni A, Barberis M, Colombo N, Multinu F. Betella I, et al. Int J Gynecol Cancer. 2022 Jun 22:ijgc-2022-003480. doi: 10.1136/ijgc-2022-003480. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35732351
In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay.
Fumagalli C, Betella I, Ranghiero A, Guerini-Rocco E, Bonaldo G, Rappa A, Vacirca D, Colombo N, Barberis M. Fumagalli C, et al. Among authors: betella i. Pathologica. 2022 Aug;114(4):288-294. doi: 10.32074/1591-951X-791. Pathologica. 2022. PMID: 36136896 Free PMC article.
21 results